SCHEMBL19299604

SCHEMBL19299604

O=C1c2ccccc2-c2cccc(-c3cc4ccccc4cc3Cl)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNMT1 P26358 3/20 0.44
▸ CASP1 P29466 2/20 0.44
▸ CASP7 P55210 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ PABPC1 P11940 1/20 0.44
▸ MAPT P10636 4/20 0.43
▸ ADORA2A P29274 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ S100A4 P26447 2/20 0.43
▸ CYP1A1 P04798 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ IDO1 P14902 1/20 0.42
▸ DNMT3L Q9UJW3 1/20 0.42
▸ DNMT3A Q9Y6K1 1/20 0.42
▸ TTR P02766 1/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ MAOA P21397 3/20 0.41
▸ CES1 P23141 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19299400 0.81 MAPT (0.46) DNMT1MAPTADORA2ALMNAALDH1A1
SCHEMBL19299398 0.79 PTPRC (0.55) DNMT1MAPTADORA2ALMNAALDH1A1
SCHEMBL19299324 0.79 DNMT1 (0.58) DNMT1CASP1CASP7CYP3A4PABPC1
SCHEMBL8671883 0.77 ADORA2A (0.57) DNMT1MAPTADORA2ALMNAALDH1A1
SCHEMBL21498259 0.76 ELANE (0.55) DNMT1CYP3A4MAPTADORA2ALMNA
SCHEMBL19299325 0.76 DNMT1 (0.50) DNMT1CASP1CASP7CYP3A4PABPC1
SCHEMBL19299421 0.73 S100A4 (0.50) DNMT1MAPTADORA2ALMNAALDH1A1
SCHEMBL31605495 0.73 CYP2A6 (0.52) CASP1CASP7MAPTALDH1A1MEN1
SCHEMBL19299392 0.73 DNMT1 (0.50) DNMT1PABPC1MAPTADORA2ALMNA
SCHEMBL19299387 0.73 CYP2A6 (0.52) DNMT1MAPTADORA2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11538996-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2022-12-27 — — US disclosed
EP-3419960-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-07-01 — — EP disclosed
US-10454041-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2019-10-22 — — US disclosed
WO-2017144150-A2 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-08-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10454041-B2 Materials for organic electroluminescent devices RIF1, INTS9, LEF1 DNMT1 450/4885CASP1 1401/4885CASP7 4555/4885
US-11538996-B2 Materials for organic electroluminescent devices RIF1, INTS9, LEF1 DNMT1 450/4885CASP1 1401/4885CASP7 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback